Precision in clinical trials summit San Francisco
The Precision in Clinical Trials summit will be a unique platform for the largest bio-pharmaceutical hub in the region to network and discuss collaboration in order to achieve their outsourcing and operational strategies. The summit is tailor-made to address the concerns of trial sponsors who are conducting clinical trials at a local and global level. With an innovation-focused agenda, pre-scheduled meetings between potential collaborators and a host of reliable solution providers, the summit is designed to help attendees find solutions to their most pressing clinical trial challenges in 2022 and beyond.
Stop by the Clario booth during the conference to talk with our experts about what is new and how we can help you be successful with your clinical trials.
Session Information:
Title: eConsent – Driving Successful Adoption
Date: Monday, November 14th, 2022
Time: 10:00 a.m. – 10:30 a.m. PST
Electronic Informed Consent (eConsent) is fast becoming a necessity for clinical trial efficiency, reduction of administrative burden and better patient engagement.
Join Clario as we share best practices for driving adoption of eConsent and how sites and sponsors can overcome common barriers. We will discuss the many misconceptions of eConsent including how some view it through the narrow prism of electronic signature, rather than focusing on the broader benefits of an informed electronic consent process from a patient and site perspective.
Presenter
Nancy DiCristo
Sr. Account Executive, Business Development at Clario
Nancy is a Senior Account Executive who manages the CRO and East Coast sales team and channels within Clario Software Solutions. She is an experienced life science professional with a successful track record in operational and commercial management, supporting protocol forecasting, site and vendor management, governance, and software business development. Having started her career on the sponsor side of the industry, Nancy worked at organizations including Schering-Plough and Celgene Corp to support global trials all the way to market for drugs such as apremilast (OTEZLA – US) and pomalidomid (POMALYST – EU). Nancy established her own consulting firm (ND Pharma Consulting, LLC) before joining Clario in 2017.